Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner. It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment. The company was founded in 2005 and is based in Guangzhou, China.
Frequently asked questions
What sector does Guangzhou LBP Medicine Science & Technology Co Ltd (688393) operate in?
Guangzhou LBP Medicine Science & Technology Co Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Guangzhou LBP Medicine Science & Technology Co Ltd (688393) current stock price?
As of the latest data, Guangzhou LBP Medicine Science & Technology Co Ltd stock price is CN¥22.21, with a previous close of CN¥22.53. Guangzhou LBP Medicine Science & Technology Co Ltd lost -CN¥0.32 in the last trading session, representing a -1.42% loss.
What is Guangzhou LBP Medicine Science & Technology Co Ltd (688393) current market capitalization?
Guangzhou LBP Medicine Science & Technology Co Ltd market cap is approximately 2.08 billion.
What is Guangzhou LBP Medicine Science & Technology Co Ltd (688393) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.36.
Does Guangzhou LBP Medicine Science & Technology Co Ltd (688393) pay dividends?
Yes. Guangzhou LBP Medicine Science & Technology Co Ltd pays annual dividends with an annualized yield of 0.45% and an estimated annual payout of CN¥0.10 per share.
When is the next ex-dividend date for Guangzhou LBP Medicine Science & Technology Co Ltd (688393)?
The next ex-dividend date is scheduled for June 03, 2027.
What is Guangzhou LBP Medicine Science & Technology Co Ltd (688393) beta (volatility) score?
Guangzhou LBP Medicine Science & Technology Co Ltd has a beta of 0.487, indicating lower volatility than the overall market.